Extremely not long ago, preliminary outcomes from a 3rd demo comparing ibrutinib versus observation were being offered.a hundred and five Sufferers receiving ibrutinib had a longer celebration-absolutely free survival, but no All round survival gain, Even though the success were being nevertheless i